See also this year's filing and all EDGAR filings for this company.
PDF Report 0001034842_2025_Rigel_Pharmaceuticals_INC.pdf
Logs
| error | Negative Expenses, ignoring company. | pre-agg | {'expenses': -69061000} |
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001034842, Rigel Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 135,103,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 92,000 |
| 3 | remainder_Assets | 28,781,000 |
| 4 | LiabilitiesCurrent | 63,299,000 |
| 5 | LiabilitiesNoncurrent | 39,981,000 |
| 6 | remainder_Liabilities | 57,408,000 |
| 7 | CostOfGoodsAndServicesSold | 76,307,315 |
| 8 | SellingGeneralAndAdministrativeExpense | 113,964,931 |
| 9 | ResearchAndDevelopmentExpense | 23,355,950 |
| 10 | remainder_Expenses | 8,249,256 |
| 11 | remainder_Revenues | 205,258,701 |
| 12 | remainder_NetIncome | 2,089,554 |
| 13 | remainder_ComprehensiveNetIncome | 21,695 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 163,976,000 |
| 1 | Liabilities | 160,688,000 |
| 2 | Expenses | 221,877,452 |
| 3 | Revenues | 205,258,701 |
| 4 | StockholdersEquity | 3,288,000 |
| 5 | NetIncome | -14,529,197 |
| 6 | ComprehensiveNetIncome | -14,518,350 |
| 7 | BaseVar | 376,955,701 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.0453 |
| 9 | EconomicCapitalRatio | 1.41 |
Edgar->Model Mapping
Feature Distribution
Change over Time
